Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

REPONEX PHARMACEUTICALS A/S

Quicksearch from your own companies XBRLDenmarkIFRS Analyst: XBRLDenmarkIFRS

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2011 N/A 2012 N/A 2013 N/A 2014 N/A 2015 N/A 2016 2016/12 2017e N/A 2018e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   0.0% 0.0% 0.0% 0.0% 0.0% 2.7% 8.0% 8.1%   Credit score (0-100)   0 0 0 0 0 63 32 32   Credit rating   N/A N/A N/A N/A N/A BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2011 N/A 2012 N/A 2013 N/A 2014 N/A 2015 N/A 2016 2016/12 2017e N/A 2018e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 0.0 0.0 0.0 0.0 241 0.0 0.0   EBITDA   0.0 0.0 0.0 0.0 0.0 -302 0.0 0.0   EBIT   0.0 0.0 0.0 0.0 0.0 -302 0.0 0.0   Pre-tax profit (PTP)   0.0 0.0 0.0 0.0 0.0 -420.0 0.0 0.0   Net earnings   0.0 0.0 0.0 0.0 0.0 -332.0 0.0 0.0   Pre-tax profit without non-rec. items   0.0 0.0 0.0 0.0 0.0 -420 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2011 N/A 2012 N/A 2013 N/A 2014 N/A 2015 N/A 2016 2016/12 2017e N/A 2018e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   0.0 0.0 0.0 0.0 0.0 5,229 -3,512 -3,512   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 6,169 6,169   Balance sheet total (assets)   0.0 0.0 0.0 0.0 0.0 7,942 2,657 2,657   Net Debt   0.0 0.0 0.0 0.0 0.0 -2,658 6,169 6,169     See the entire balance sheet 1000.0 Volume  2011 N/A 2012 N/A 2013 N/A 2014 N/A 2015 N/A 2016 2016/12 2017e N/A 2018e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 0.0 0.0 0.0 0.0 241 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 0 0 0 0 7,942 2,657 2,657   Balance sheet change%   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -66.5% 0.0%   Added value   0.0 0.0 0.0 0.0 0.0 -302.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 3,992 -1,335 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 0.0 0.0 0.0 0.0 -1.0 0.0 0.0   1000.0 Profitability  2011 N/A 2012 N/A 2013 N/A 2014 N/A 2015 N/A 2016 2016/12 2017e N/A 2018e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 0.0% 0.0% 0.0% 0.0% -125.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% 0.0% 0.0% 0.0% 0.0% -3.8% 0.0% 0.0%   ROI %   0.0% 0.0% 0.0% 0.0% 0.0% -4.0% 0.0% 0.0%   ROE %   0.0% 0.0% 0.0% 0.0% 0.0% -6.3% 0.0% 0.0%   1000.0 Solidity  2011 N/A 2012 N/A 2013 N/A 2014 N/A 2015 N/A 2016 2016/12 2017e N/A 2018e N/A Equity ratio %   0.0% 0.0% 0.0% 0.0% 0.0% 65.8% -56.9% -56.9%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 0.0% 0.0% 0.0% 880.1% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -175.7% -175.7%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2011 N/A 2012 N/A 2013 N/A 2014 N/A 2015 N/A 2016 2016/12 2017e N/A 2018e N/A Quick Ratio   0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0   Current Ratio   0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 0.0 2,658.0 0.0 0.0   1000.0 Capital use efficiency  2011 N/A 2012 N/A 2013 N/A 2014 N/A 2015 N/A 2016 2016/12 2017e N/A 2018e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 0.0 0.0 0.0 0.0 3,563.0 -3,084.5 -3,084.5   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2011 N/A 2012 N/A 2013 N/A 2014 N/A 2015 N/A 2016 2016/12 2017e N/A 2018e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0